These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 25869298

  • 1. Signal transducer and activator of transcription (STAT) 3 inhibition delays the onset of lupus nephritis in MRL/lpr mice.
    Edwards LJ, Mizui M, Kyttaris V.
    Clin Immunol; 2015 Jun; 158(2):221-30. PubMed ID: 25869298
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
    Dang WZ, Li H, Jiang B, Nandakumar KS, Liu KF, Liu LX, Yu XC, Tan HJ, Zhou C.
    Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
    [Abstract] [Full Text] [Related]

  • 3. Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells.
    Yao L, Chen HP, Ma Q.
    Immunol Lett; 2014 Sep; 161(1):76-80. PubMed ID: 24837470
    [Abstract] [Full Text] [Related]

  • 4. T cell-specific STAT3 deficiency abrogates lupus nephritis.
    Yoshida N, He F, Kyttaris VC.
    Lupus; 2019 Oct; 28(12):1468-1472. PubMed ID: 31551033
    [Abstract] [Full Text] [Related]

  • 5. Interleukin-9 Is Associated with Elevated Anti-Double-Stranded DNA Antibodies in Lupus-Prone Mice.
    Yang J, Li Q, Yang X, Li M.
    Mol Med; 2015 Apr 15; 21(1):364-70. PubMed ID: 25902303
    [Abstract] [Full Text] [Related]

  • 6. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM, Turner JE, Paust HJ, Lindner M, Peters A, Heiss K, Velden J, Hopfer H, Fehr S, Krieger T, Meyer-Schwesinger C, Meyer TN, Helmchen U, Mittrücker HW, Stahl RA, Panzer U.
    J Immunol; 2009 Oct 01; 183(7):4693-704. PubMed ID: 19734217
    [Abstract] [Full Text] [Related]

  • 7. S3I-201 ameliorates tubulointerstitial lesion of the kidneys in MRL/lpr mice.
    Du Y, Zhang W, Liu S, Feng X, Gao F, Liu Q.
    Biochem Biophys Res Commun; 2018 Sep 03; 503(1):177-180. PubMed ID: 29885836
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-22 From Type 3 Innate Lymphoid Cells Aggravates Lupus Nephritis by Promoting Macrophage Infiltration in Lupus-Prone Mice.
    Hu L, Hu J, Chen L, Zhang Y, Wang Q, Yang X.
    Front Immunol; 2021 Sep 03; 12():584414. PubMed ID: 33717066
    [Abstract] [Full Text] [Related]

  • 9. [Expression of STAT3 and PIAS3 in renal tissues of MRL/lpr mice].
    Yang H, Xu A, Lv J, Liu Y.
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun 03; 32(6):821-5. PubMed ID: 22699062
    [Abstract] [Full Text] [Related]

  • 10. Erythropoietin Treatment Ameliorates Lupus Nephritis of MRL/lpr Mice.
    Zhang Z, Liu D, Zhang X, Wang X.
    Inflammation; 2018 Oct 03; 41(5):1888-1899. PubMed ID: 29951872
    [Abstract] [Full Text] [Related]

  • 11. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
    Ji J, Fan H, Li F, Li X, Dong G, Gong W, Song Y, Liu F, Hua C, Tan R, Dou H, Hou Y.
    Immunol Lett; 2015 Dec 03; 168(2):355-65. PubMed ID: 26545567
    [Abstract] [Full Text] [Related]

  • 12. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H, Relle M, Menke J, Brochhausen C, Jones SA, Topley N, Galle PR, Schwarting A.
    J Rheumatol; 2010 Jan 03; 37(1):60-70. PubMed ID: 19955044
    [Abstract] [Full Text] [Related]

  • 13. Function of the Th17/interleukin-17A immune response in murine lupus nephritis.
    Schmidt T, Paust HJ, Krebs CF, Turner JE, Kaffke A, Bennstein SB, Koyro T, Peters A, Velden J, Hünemörder S, Haag F, Steinmetz OM, Mittrücker HW, Stahl RA, Panzer U.
    Arthritis Rheumatol; 2015 Feb 03; 67(2):475-87. PubMed ID: 25385550
    [Abstract] [Full Text] [Related]

  • 14. Cryptotanshinone ameliorates the pathogenesis of systemic lupus erythematosus by blocking T cell proliferation.
    Du Y, Du L, He Z, Zhou J, Wen C, Zhang Y.
    Int Immunopharmacol; 2019 Sep 03; 74():105677. PubMed ID: 31177018
    [Abstract] [Full Text] [Related]

  • 15. STAT3 inhibition ameliorates renal interstitial inflammation in MRL/lpr mice with diffuse proliferative lupus nephritis.
    Zhu J, Chen Y, Chen Y, Lv Y, Chen T.
    Ren Fail; 2024 Dec 03; 46(1):2358187. PubMed ID: 38803234
    [Abstract] [Full Text] [Related]

  • 16. Retinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease.
    Pérez de Lema G, Lucio-Cazaña FJ, Molina A, Luckow B, Schmid H, de Wit C, Moreno-Manzano V, Banas B, Mampaso F, Schlöndorff D.
    Kidney Int; 2004 Sep 03; 66(3):1018-28. PubMed ID: 15327395
    [Abstract] [Full Text] [Related]

  • 17. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.
    Mannoor K, Matejuk A, Xu Y, Beardall M, Chen C.
    J Immunol; 2012 Apr 15; 188(8):3628-38. PubMed ID: 22407922
    [Abstract] [Full Text] [Related]

  • 18. IK cytokine ameliorates the progression of lupus nephritis in MRL/lpr mice.
    Muraoka M, Hasegawa H, Kohno M, Inoue A, Miyazaki T, Terada M, Nose M, Yasukawa M.
    Arthritis Rheum; 2006 Nov 15; 54(11):3591-600. PubMed ID: 17075801
    [Abstract] [Full Text] [Related]

  • 19. Glomerular cytokine expression in murine lupus nephritis.
    Tshilela KA, Ikeuchi H, Matsumoto T, Kuroiwa T, Sakurai N, Sakairi T, Kaneko Y, Maeshima A, Hiromura K, Nojima Y.
    Clin Exp Nephrol; 2016 Feb 15; 20(1):23-9. PubMed ID: 25985839
    [Abstract] [Full Text] [Related]

  • 20. Anti-prolactin treatment alleviates lupus conditions by regulating the JAK2-STAT3 pathway.
    Jiang Y, Chen H, Lin J, Pan J, Shen Y, Li Q.
    Clin Exp Pharmacol Physiol; 2023 Dec 15; 50(12):936-943. PubMed ID: 37727880
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.